Radiopaque enhanced cobalt alloy for stents
US-11141296-B2 · Oct 12, 2021 · US
US11779477B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11779477-B2 |
| Application number | US-202117562592-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 27, 2021 |
| Priority date | Nov 17, 2010 |
| Publication date | Oct 10, 2023 |
| Grant date | Oct 10, 2023 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A stent having a cobalt-based alloy, wherein the cobalt-based alloy is free of nickel (Ni), the cobalt-based alloy including 10-65 weight % metal member selected from a platinum group metal, a refractory metal, or combinations thereof, 15-25 weight % chromium (Cr), 4-7 weight % molybdenum (Mo), 0-18 weight % iron (Fe), and 22-40 weight % cobalt (Co).
Opening claim text (preview).
The invention claimed is: 1. A stent comprising: a cobalt-based alloy, wherein the cobalt-based alloy is free of nickel (Ni), the cobalt-based alloy consisting of: 10-65 weight % metal member selected from, the group consisting of silver, gold, hafnium, niobium, rhenium, tantalum, zirconium, platinum, palladium, ruthenium, rhodium, osmium, iridium and combinations thereof; 15-25 weight % chromium (Cr); 4-7 weight % molybdenum (Mo); 0-18 weight % iron (Fe); 22-40 weight % cobalt (Co); and 0-2 weight % of manganese. 2. The stent of claim 1 , wherein the stent has a minimum ultimate tensile strength of 125 ksi. 3. The stent of claim 1 , wherein the stent has a minimum yield strength of 45 ksi. 4. The stent of claim 1 , wherein the stent has a minimum total elongation of 30%. 5. The stent of claim 1 , wherein the metal member is selected from the group consisting of silver, gold, hafnium, niobium, rhenium, tantalum, zirconium, and combinations thereof. 6. The stent of claim 1 , wherein the metal member is selected from the group consisting of platinum, palladium, ruthenium, rhodium, osmium, iridium, and combinations thereof. 7. A stent comprising: a cobalt-based alloy, wherein the cobalt-based alloy is free of nickel (Ni), the cobalt-based alloy consisting of: 10-60 weight % metal member selected from the group consisting of silver, gold, hafnium, niobium, rhenium, tantalum, zirconium and combinations thereof; 10-25 weight % chromium (Cr); 18-55 weight % cobalt (Co); 0-3 weight % iron (Fe); 0-3 weight % manganese (Mn); 0-10 weight % molybdenum (Mo); and optionally, one or more trace elements selected from the group consisting of beryllium, boron, carbon, phosphorus, silicon, sulfur, and titanium. 8. The stent of claim 7 , wherein the refractor-metal member is 10-45 weight %. 9. The stent of claim 7 , wherein the beryllium, the boron, or the carbon are in lower concentration than L-605 standard permits. 10. A stent comprising: a cobalt-based alloy, wherein the cobalt-based alloy is free of nickel (Ni), the cobalt-based alloy consisting of: 10-65 weight % metal member selected from the group consisting of platinum, palladium, ruthenium, rhodium, osmium, iridium and combinations thereof; 10-25 weight % chromium (Cr); 18-50 weight % cobalt (Co); 10-about 15 weight % tungsten (W); 0-about 2 weight % manganese (Mn); and 0-about 3 weight % iron (Fe). 11. The stent of claim 10 , wherein the metal member comprises at least one of platinum, or palladium. 12. A stent comprising: a cobalt-based alloy, wherein the cobalt-based alloy is free of nickel (Ni), the cobalt-based alloy comprising: 10-65 weight % metal member selected from the group consisting of silver, gold, hafnium, niobium, rhenium, tantalum, zirconium, platinum, palladium, ruthenium, rhodium, osmium, iridium, and combinations thereof; 15-25 weight % chromium (Cr); 4-7 weight % molybdenum (Mo); 0-18 weight % iron (Fe); 22-40 weight % cobalt (Co); and 0-2 weight % of manganese; wherein the alloy has a single-phase microstructure.
Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents (stent-grafts for tubular structures of the body other than blood vessels A61F2/04; stent-grafts for blood vessels A61F2/07) · CPC title
Blood vessels · CPC title
Metals or alloys · CPC title
Materials at least partially X-ray or laser opaque · CPC title
Nickel- or cobalt-based alloys · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.